3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Solid Malignant Tumors
1
Recurrence
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
6
pembrolizumab
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Fulvestrant
3
palbociclib
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Radiation Dose Hypofractionation
2
Radiation
2
Platinum
2
Paclitaxel
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Congresses as Topic
2
Carboplatin
2
Brachytherapy
2
Biopsy
2
Bevacizumab
2
Axitinib
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tisotumab vedotin
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
regorafenib
×
30 days
×
Clear all
No trials found.